MoneyWorks4Me

Marksans Pharma informs about statement of investor complaints

10 Jan 2018 Evaluate

Marksans Pharma has informed about Statement of Investor Complaints for the quarter ended December, 2017 under Regulation 13(3) of SEBI (LODR), 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..